She sat at her kitchen table, laptop open, watching the small icon in the system tray. HelixDLP_Monitor.exe. Running for 1,247 days. Uploading every file she touched, every draft she wrote, every search she made.
While she slept.
The coffee she'd made at 4 AM had gone cold. The sky outside her window was beginning to lighten—not sunrise yet, but the deep blue that preceded it. Wednesday morning. Seven days since her second visit to Tidewater. Seven days since Shizuka had given her his six conditions.
She had fourteen days total. Half the time was already gone.
Yuna pulled up a new document. Titled it: SHIZUKA_UMINO_COMPLETE_ASSESSMENT.docx
The filename would be logged. HelixGen would see it the moment she started typing. They'd see every word as she wrote it.
Good. Let them see.
She began with Shizuka's first condition: Start with facts only.
Section 1: Medical History
Subject Z-0 (Shizuka Umino) entered telomerase control treatment March 2020 at age 9. Pre-treatment diagnosis: congenital multi-organ dysfunction syndrome with projected survival of 8-12 weeks without intervention.
Treatment Protocol: Continuous telomerase activation with real-time biosignal monitoring. Objective: cellular regeneration at controlled rate to prevent cascade failure.
Result: Patient survival extended beyond initial prognosis. However, treatment generated secondary complications requiring permanent medical supervision.
Yuna stopped. Read it back. Clinical. Factual. Accurate.
But it missed everything that mattered.
She thought about Shizuka's second condition: Explain what it costs to live this way.
"Rose," she said quietly. "Pull up the incident frequency data. All of it."
The screen populated with graphs. Five years of data. Forty-seven incidents in the first month. One in the most recent month.
"Rose, can you calculate the total hours Shizuka has spent in active crisis management?"
"Processing... Calculating based on documented incident duration, recovery periods, and baseline elevation windows... Estimated total: 4,347 hours."
"Four thousand hours."
"Approximately 181 days. Approximately six months of his life spent in active physiological crisis or recovery."
Yuna added to the document:
Cost Assessment: Subject has experienced 847 documented cardiac incidents over five years. Average recovery time per incident: 5.1 hours. Cumulative time spent in crisis or recovery state: approximately 4,347 hours (181 days).
This does not account for baseline stress elevation, sleep disruption, or constant monitoring requirements. Subject reports: "Every second is observation. I'm feeling something and watching myself feel it and adjusting the feeling and monitoring the adjustment."
She paused again. Was this too clinical? Or not clinical enough?
"Rose, I need your analysis. Am I balancing facts and impact appropriately?"
"Analyzing document structure... Current approach maintains factual accuracy while providing contextual impact data. However, you have not yet addressed Condition 3: Explain why this happened to him specifically."
Right. Why Shizuka.
Yuna pulled up the deleted files Rose had reconstructed. The consent form. The parent signature. Dr. Takeshi Umino's research history.
Why Subject Z-0: Subject's father, Dr. Takeshi Umino, developed the telomerase control protocol specifically to treat his son's terminal condition. Treatment was administered under emergency medical circumstances with parental consent. The subject was nine years old at time of consent.
Ethical Context: While parental consent is legally sufficient for medical procedures on minors, the experimental nature of the treatment and its permanent consequences raise questions about informed assent. Subject states: "I was nine. I didn't understand what that meant."
However, Subject also states: "I chose this. I'm fourteen now, and I understand what happened, and I'm telling you: I chose to live." This represents evolved consent—initial choice made without full understanding, later affirmed with complete awareness of consequences.
Yuna leaned back from the laptop. The sky outside was lighter now. Pink edging into the blue.
She'd been writing for two hours. The document was 2,847 words so far.
And HelixGen had been watching every word.
8:30 AM
Yuna's phone buzzed. Text from an unknown number—but the caller ID showed something odd: HelixGen Internal. Not blocked. Not anonymous. Internal.
Your document is well-written. But you're missing the key question.
Yuna stared at the message. Someone inside HelixGen. Someone with access to internal systems. Someone watching her write in real-time.
She typed back: What question?
Three dots appeared. Then:
What happens next? You're documenting what was done to him. But what about what will be done to others? HelixGen's internal communications show pressure to expand human trials. Your document ends the past. But it doesn't address the future.
Yuna's hands were shaking. This wasn't HelixGen. The tone was wrong. Too direct. Too... helpful?
Who is this?
Someone who's been watching longer than you have. Someone who understands that documentation isn't enough. You need a path forward.
The message felt wrong. Manipulation disguised as assistance. But the question itself was valid.
What happens next?
She'd been so focused on Shizuka's story—on documenting what had been done, on ensuring people knew—that she hadn't fully addressed the systemic question. The technology existed. People were already dependent on it. What did disclosure actually accomplish?
Yuna added a new section to the document:
Section 4: Implications for Future Applications
Current status: Subject Z-0 remains the only documented human subject of telomerase control treatment. However, HelixGen's internal communications suggest institutional pressure to expand human trials following successful animal model results.
Disclosure Impact: Public awareness of Subject Z-0's experience will likely trigger regulatory review before any expansion occurs. This creates an opportunity to establish informed consent frameworks and safety protocols before additional human subjects are enrolled.
Recommendation: If the technology advances to broader application, regulatory frameworks must be established proactively. Future patients deserve complete understanding of both potential benefits and documented costs before treatment begins.
She was writing policy recommendations. That felt wrong. She was a researcher, not a lawmaker.
But Shizuka's fourth condition: Tell people what they're choosing. That required more than just his story. It required context for the choice.
"Rose, am I overstepping? This section reads more like advocacy than documentation."
"Analyzing... The section provides necessary context for informed decision-making. However, it does introduce subjective policy recommendations. Alternative approach: present multiple possible responses without endorsing specific outcomes."
Yuna revised:
Possible Responses to Disclosure: 1. Immediate cessation of all telomerase research (eliminates future risk) 2. Continuation of research under enhanced regulatory oversight (moderate complexity) 3. Accelerated approval with mandatory informed consent protocols (balances access and safety) 4. Maintenance of current research-only status (preserves status quo)
Each option has distinct ethical and practical implications. This document provides information for stakeholders to make informed choices.
Better. Less prescriptive. More aligned with Shizuka's desire for informed choice rather than imposed solutions.
Her phone buzzed again. The same unknown number:
Better. Now you're thinking systemically. But you're still missing one critical element: verification.
Yuna frowned. Verification?
Your document describes Subject Z-0's experience. But you haven't provided independent verification. Medical records, biosignal data, expert analysis. Without that, this reads like a story. Not evidence.
The sender was right. Damn them.
Yuna had incident logs. She had Rose's analysis. She had Umino's notebook. But none of that constituted independent medical verification.
She couldn't access Tidewater's official records—her credentials were revoked. She couldn't compel HelixGen to release data. And asking Umino would put him at risk.
Unless...
"Rose, the biosignal data you cached. Can you generate a technical analysis that would constitute independent verification?"
"Negative. I am not recognized as an independent authority. Any analysis I produce would be classified as 'AI-assisted documentation' rather than expert verification."
"Then what do I have?"
"You have: firsthand observation (your visits), subject testimony (Shizuka's statements), guardian testimony (Dr. Umino's notebook), and secondary data (cached incident logs). These constitute credible documentation but not formal medical verification."
In other words: enough to be believed, not enough to be proven.
Yuna's phone buzzed a third time:
There's one person who can provide verification. Dr. Matsuda. She's been Shizuka's primary observer for four years. Her medical opinion would carry weight. But she reports to HelixGen.
This was getting too specific. Whoever this was, they knew the internal structure.
Yuna typed: Are you Dr. Matsuda?
Long pause. Then:
No. But I know what she put in her last report. She documented your visit. She documented Shizuka's conditions. She documented her intention to provide honest assessment. HelixGen received that report 48 hours ago.
If you contact her directly and ask for medical verification... she might provide it. It's a risk for her. But her report already committed her to honesty.
Yuna's chest tightened. Contact Matsuda directly? That would be circumventing HelixGen's oversight. That would be asking Matsuda to choose between her employer and her professional ethics.
But it was also exactly what Shizuka had asked for: If someone asks Dr. Matsuda for truth, she'll give it.
Stolen content warning: this tale belongs on Royal Road. Report any occurrences elsewhere.
11:00 AM
Yuna sat in her car outside Tidewater's parking lot. Not in the lot itself—that would trigger security alerts. She was parked at the hiking trailhead half a kilometer away, the same place she'd used during her first surveillance.
She'd driven four hours on impulse. Or not impulse. Calculation. If she was going to ask Matsuda for verification, it had to be face-to-face. Not email. Not phone. Direct request, direct response.
She pulled out her phone and texted the number Umino had given her months ago—Matsuda's personal line for family emergencies.
Dr. Matsuda, this is Yuna Shirasaki. I'm near the facility. I need to speak with you about Shizuka's medical records. Not officially. Personally. Can you meet me at the north trailhead in 20 minutes?
She waited. The phone sat silent on the dashboard. Two minutes. Five minutes.
Then:
I can't leave the facility during my shift. But I take my break at 12:15. There's a service road behind the building. Follow it uphill. I'll meet you there. Come alone.
Yuna's hands were shaking again.
This was it. The line between documentation and action.
12:20 PM
The service road was narrow, barely wide enough for a single vehicle. It switchbacked up the cliff behind Tidewater, probably used for maintenance access. Yuna climbed on foot, the ocean visible through gaps in the trees.
Dr. Matsuda was waiting at a small clearing. She stood with her back to the view, arms crossed, expression unreadable.
"You shouldn't be here," Matsuda said. Not hostile. Just factual.
"I know. But I need your help."
"HelixGen is monitoring you. They know you're preparing a disclosure document. They're preparing their response."
"I know that too. I found the DLP monitor on my laptop."
Matsuda's expression shifted. Surprise? "And you came anyway."
"Because Shizuka asked for truth. And he said you'd provide it if asked directly." Yuna pulled out her phone, showed Matsuda the document outline. "I'm writing a complete assessment of his condition. But it needs medical verification. Your professional opinion."
Matsuda read the screen. Her face remained neutral, but Yuna saw the small tension at the corner of her eyes. Reading. Evaluating.
"This is accurate," Matsuda said finally. "The incident counts, the recovery data, the cost analysis. It's all accurate."
"Will you say that officially? As Shizuka's primary physician?"
"If I do, HelixGen will terminate my employment. Possibly pursue legal action for breach of confidentiality."
"I know. That's why I'm asking rather than demanding. This is your choice."
Matsuda looked past Yuna, toward the ocean. The wind moved through the trees—that constant sound that Shizuka couldn't safely hear without monitoring.
"Four years," Matsuda said quietly. "I've been monitoring him for four years. I've watched him adapt. I've watched him pay the cost. I've documented every incident, every recovery, every small victory." She turned back to Yuna. "I've never once asked him if this was what he wanted. Because I assumed I knew the answer. That he'd want to live, regardless of cost."
"And now?"
"Now he's told you his conditions. And one of them is that people know the truth." Matsuda pulled out her own phone. "I can't write you an official medical report. That would be a clear violation. But I can answer specific questions you send me. On the record. Documented. If HelixGen wants to fire me for responding to legitimate medical inquiries... they can try."
Yuna felt something loosen in her chest. "Why are you doing this?"
Matsuda's expression was tired but resolute. "Because he's fourteen years old. And he deserves to have his story told accurately. Not as corporate property. Not as a miracle of science. As a human being who made an impossible choice and lives with it every day."
She typed something on her phone. Yuna's device buzzed.
Email from: []
Subject: Re: Medical Inquiry - Subject Z-0
Dr. Shirasaki,
In response to your inquiry regarding Subject Z-0's medical status:
I have served as primary physician for this patient since June 2020. The clinical data you have documented is accurate to my professional knowledge. The subject has demonstrated unprecedented physiological adaptation, including voluntary control of autonomic processes typically considered involuntary.
However, this adaptation has required continuous medical supervision and comes with significant quality-of-life restrictions. The subject cannot safely experience: sudden auditory stimuli, strong olfactory triggers, or emotional intensity without risk of cardiac dysregulation.
The subject is cognitively intact, emotionally mature beyond chronological age, and capable of informed medical decision-making. Any disclosure of his condition should be done with his explicit consent and in accordance with his stated preferences.
This assessment is provided in my capacity as a licensed physician.
Dr. Keiko Matsuda, MD Internal Medicine / Specialized Care
Yuna read it twice. Then looked up at Matsuda. "You just ended your career."
"Possibly. Or HelixGen decides that firing me creates more problems than it solves." Matsuda's voice was steady. "Either way, Shizuka's condition has been medically verified. You have what you need."
"Thank you."
"Don't thank me. Just... do it right. His trust is the most valuable thing he has left. Don't waste it."
Matsuda walked back toward the facility. Yuna stood alone on the service road, phone in hand, email on screen.
Medical verification. Independent expert opinion. The missing piece.
4:00 PM - Back at Apartment
Yuna sat at her kitchen table, the completed document open on her laptop.
7,894 words. Sixteen pages. Everything Shizuka had asked for:
- Facts only - opening section ?
- Cost explanation - incident data and recovery analysis ?
- Why him specifically - father's choice, emergency circumstances ?
- What people are choosing - implications for future decisions ?
- Medical verification - Matsuda's expert assessment ?
- Emphasis on his choice - "I chose this" highlighted throughout ?
The document was complete. Accurate. Verified. Ready.
Now she needed to decide: who receives it?
"Rose, I need your analysis. Three options: medical ethics board, investigative journalist, or government regulatory agency. What are the outcomes?"
Rose's voice came through the speakers. "Analyzing probable outcomes based on 214 comparable cases of medical disclosure:
Medical Ethics Board:
- Probability of immediate action: Low
- Probability of prolonged review: High
- Probability of being ignored: Very Low
- Estimated timeline to public disclosure: 6-18 months
- Control over narrative: Low (academic language)
Investigative Journalist:
- Probability of immediate action: Very High
- Probability of sensationalization: Moderate
- Probability of accurate representation: High
- Estimated timeline to public disclosure: 2-6 weeks
- Control over narrative: Moderate (collaborative editing possible)
Government Regulatory Agency:
- Probability of immediate action: Moderate
- Probability of suppression: Moderate
- Probability of quiet policy change: Low-Moderate
- Estimated timeline to public disclosure: Uncertain (never to 12+ months)
- Control over narrative: Very Low (classified proceedings)
Each option has distinct risk profiles. Recommendation depends on prioritization: speed, accuracy, or systemic change."
Yuna stared at the analysis. Shizuka had said: I want people to know. That suggested speed mattered. But he'd also said: Tell them accurately. That suggested control mattered too.
Medical board: slow, accurate, no guarantee of public disclosure. Journalist: fast, risky sensationalization, likely public. Government: uncertain, possibly buried, might trigger regulation.
Or...
"Rose, what if I send it to all three simultaneously?"
"Analyzing... Multiple distribution increases probability of disclosure but reduces control over timing and framing. Once information reaches multiple recipients, narrative coherence becomes difficult to maintain. However, it does prevent any single recipient from suppressing the information entirely."
Multiple distribution. Maximum spread. Minimum control.
That felt chaotic. But maybe chaos was the point. Maybe the only way to ensure people actually knew was to make the information impossible to contain.
Yuna pulled up three email addresses:
- Dr. Haruki Tanaka - Chair, National Medical Ethics Board
- Dr. Kenji Akiyama - Science Journalist, The Independent Press
- Ministry of Health, Labor and Welfare - Medical Safety Division
Her cursor hovered over the "send" button.
Then her phone buzzed. The unknown number again:
You're about to send it. Don't.
Yuna's blood went cold. They were watching. Real-time watching.
Why not?
Because HelixGen's response is already prepared. The moment that document leaves your system, they execute a counter-narrative. Patient privacy violation. Unauthorized disclosure of minor's medical records. They'll bury you in legal action before anyone reads past the first page.
You need something else. Something that makes suppression impossible.
Yuna typed: What?
Shizuka himself. Not just his story. Him. On record. Speaking. Choosing.
They can suppress documents. They can't suppress a fourteen-year-old boy saying "I chose this" directly to the world.
Yuna's hands were shaking. "Rose, is this... is this right? Should I wait?"
"Insufficient data to determine sender's reliability. However, their analysis of HelixGen's legal strategy is consistent with corporate crisis management protocols. A privacy violation claim would be effective at delaying disclosure."
The sender was right. Damn them again.
Just a document wasn't enough. Shizuka needed to be present. Not as Subject Z-0. As Shizuka Umino. Fourteen years old. Choosing.
But that meant asking him to step forward. To become visible. To accept all the consequences he'd listed in his conditions.
That was his choice to make. Not hers.
Yuna closed the email draft. Saved the document. And pulled up a different message:
To: takahashi.k.personal@[...] Subject: I need to ask Shizuka something
Mr. Umino,
The document is ready. But I think it needs something more. I think Shizuka needs to be the one who presents it. Not me explaining him. Him explaining himself.
This means asking him to go public. Fully public. Name, face, voice. Everything he's been protected from for five years.
I won't do this without asking him first. But I need to ask. Can you arrange another visit?
- Yuna
She hit send.
Then she waited.
Outside, the sun was setting. The apartment was getting dark. Yuna didn't turn on the lights. Just sat in the growing shadows, watching her laptop screen, watching the small icon in the system tray.
HelixDLP_Monitor.exe
Still running. Still uploading.
They'd seen everything. The document. The email to Umino. The decision not to send.
They knew what she was planning.
And they were preparing their response.
10:47 PM
Yuna's phone buzzed. Text from Umino:
He says yes.
Three words. But they changed everything.
A second message:
He wants to meet you. Not at Tidewater. Somewhere outside. He says if he's going to tell the world who he is, he should do it somewhere that isn't a cage.
Yuna's heart was pounding. Of course. Shizuka wanted out. Even for two hours. Even under supervision.
HelixGen has conditionally approved an outdoor session. Sunday morning. Wagu harbor. You, him, his father, Dr. Matsuda. Two hours maximum. Medical team on standby.
But he has one more condition.
Yuna's fingers hesitated over the keyboard. What condition?
He wants to touch the ocean.
Yuna stared at the screen. The ocean. The single most dangerous trigger in Shizuka's environment. The smell of algae. The sound of waves. The sensory overload that had caused incidents dozens of times.
He wanted to touch it.
He says: "If I'm going to ask people to know me, I should know what I'm asking them to understand. I should know what the world actually feels like."
Two hours later - 9:31 PM
Another message. Same number. HelixGen Internal.
HelixGen medical team rejected the ocean access request. Too dangerous. Liability concerns. Assessment: "unacceptable risk to subject's physiological stability."
Of course they rejected it. A corporation wouldn't authorize an action that could kill their only human subject.
Another message:
But Shizuka gave them an ultimatum.
Yuna's breath caught.
"Let me touch the ocean, or I don't testify. Your choice."
She could imagine it. A fourteen-year-old boy sitting across from HelixGen's legal team, heart rate steady at 72 bpm, stating his terms with the same calm he used to describe arrhythmia.
They're negotiating now. Stand by.
9:47 PM
Email notification. Sender:
Yuna opened it with shaking hands.
Subject: Conditional Authorization - Ocean Access Protocol
Dr. Shirasaki,
Following emergency consultation with our medical team, legal department, and executive leadership, HelixGen Corporation has granted conditional authorization for Subject Z-0's ocean access under the following terms:
1. Full medical team on-site with emergency response capability 2. Portable monitoring equipment (cardiac, respiratory, blood pressure) 3. Maximum exposure duration: 10 minutes 4. Subject retains right to terminate exposure at any time 5. Signed liability waiver from legal guardian (Dr. Takeshi Umino) 6. All access contingent on baseline physiological stability
This authorization is granted solely at the subject's insistence and against standard medical recommendation. HelixGen Corporation assumes no responsibility for adverse outcomes resulting from this activity.
Authorized Location: Wagu Harbor, Sunday 7:30 AM Medical team will arrive at 7:00 AM for equipment setup and baseline assessment.
You are invited to observe and document the session. Subject Z-0 has requested your presence.
Legal & Compliance Division HelixGen Corporation
Yuna read the email three times.
HelixGen had been forced to choose: Grant Shizuka's demand, or lose control of the narrative entirely. Let him touch the ocean under their supervision, or risk him doing it anyway—alone, unmonitored, with no medical backup.
They chose control. Even at the risk of his life.
Or maybe—Yuna thought—they'd calculated that Shizuka's demonstrated self-regulation made the risk acceptable. After all, he'd survived Chapter 8's emotional conversation. He'd brought himself back from 139 bpm without medication.
Maybe HelixGen had done the math: Adaptive capacity increasing. Incident frequency decreasing. Risk: acceptable.
Either way, Sunday morning at 7:30 AM, a fourteen-year-old boy would touch the ocean for the first time in five years.
And HelixGen's medical team would be watching every heartbeat.
11:47 PM
Yuna made one more call before sleep.
Dr. Kenji Akiyama answered on the second ring. They'd spoken three days ago—a cautious first contact, journalist to researcher, both sensing they were circling the same hidden truth.
"Dr. Shirasaki. I wasn't expecting to hear from you again so soon."
"I have something," Yuna said. "Verifiable evidence. Direct testimony from the primary subject. Audio recording, biometric data, medical oversight. Everything documented."
A pause. Yuna could hear the shift in Akiyama's breathing—the journalist's instinct recognizing the moment.
"When?"
"Sunday morning. I'll have the full documentation by noon."
"And you're offering this to The Independent Press because...?"
"Because you've been investigating telomerase therapy independently. Because your specialization is biotechnology ethics. Because you protect your sources." Yuna kept her voice steady. "And because if this story breaks through official channels first, it gets buried in committee review for six months. The public needs to know now."
Akiyama was quiet for a moment. "If the evidence is verifiable—truly verifiable—I can publish within twenty-four hours. Sunday documentation, Monday morning edition."
"That's what I'm counting on."
"Dr. Shirasaki... you understand what you're doing? Once this is public, there's no taking it back. HelixGen will come after you. The medical establishment will question your methods. Your career—"
"I know." Yuna looked at the three email addresses on her screen. Medical board. Journalist. Government. "But a fourteen-year-old boy is going to testify to the cost of being kept alive through technology no one knows exists. The least I can do is make sure people hear him."
"Sunday noon," Akiyama confirmed. "I'll be ready."
The line went silent.
Yuna sat in the darkness of her apartment. Tomorrow morning, Shizuka would touch the ocean. Tomorrow afternoon, she would send the documentation. Tomorrow evening, the world would know.
Not because someone told her to. Because she'd decided this was right.
One final message from HelixGen Internal:
Sunday morning. 7:30 AM. Wagu harbor. Everything is arranged.
Yuna closed her eyes.
Shizuka wanted to experience the very thing that could kill him. The ocean. The waves. The smell of salt and algae. The full sensory reality he'd been protected from for five years.
Because if he was going to testify to the cost of living this way, he needed to know that cost completely.
Not safe. HelixGen's own medical team had said so: "unacceptable risk."
But Shizuka had chosen it anyway.
That's what informed consent looked like.
Yuna sat in the dark apartment. The laptop screen glowed. The DLP monitor icon blinked.
HelixGen was watching.
And in three days, Shizuka Umino was going to stand at the edge of the ocean and tell the world who he was.
If he survived it.
- KAZUYA OKAMOTO
Discussion Question: Shizuka wants to experience the ocean—the thing most likely to kill him—before going public. Is this courage or recklessness? When someone chooses danger fully informed of the risk, do we have the right to stop them? Or is allowing that choice the only way to honor their autonomy?